This week we are introducing Celbrea, a new way to identify breast health. Learn more below.

Celbrea® is an FDA-cleared Class I medical device that is painless, easy-to-use and in just 15 minutes may alert physicians and patients of a potential underlying breast pathology. Celbrea was developed to support the early detection of breast disease, including breast cancer. Their mission is to help every woman, around the world, monitor the health of their breasts.

Celbrea is a disposable and affordable device that empowers women of all ages to stay on top of monitoring their breast health. Women that can greatly benefit from the use of Celbrea include:

• Women under 40 without a recommendation to start screening, but who are concerned about the health of their breasts.

• Women with dense breasts who often need more comprehensive screenings and may be subject to a higher risk of developing breast cancer. Or women with inconclusive imaging results that require additional testing and more frequent follow-ups

• Women with gaps in access to care since the Celbrea® device is affordable and scalable, it can be especially useful for women with difficulties accessing mammography and other established standards of care.

• Women in need of more frequent or additional testing, including women with family history, genetic mutation (BRCA1, BRCA2), ethnicity and other risk factors for breast disease.

Women with gaps in access to care since the Celbrea device is affordable and scalable, it can be especially useful for women with difficulties accessing mammography and other established standards of care.

Celbrea does not replace a mammogram; it is intended to be used adjunct to, but not in place of, mammography or any other established screening procedures. If you have questions regarding Celbrea and if it’s right for you, ask your doctor or email Welwaze Medical: info@welwaze.com.